NCT00788372 - An Efficacy and Safety Study of Fentanyl in Participants With Chronic Pain | Biotech Hunter

Enrollment

142

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions

Chronic Pain

Interventions

DRUG

Fentanyl

Fentanyl transdermal patch will be applied daily starting at a dose of 12.5 mcg/hr, and up to 52 weeks. Dose will be increased as per Investigator's discretion.

Trial Locations (23)

Unknown

Amagasaki

Chūō

Fukuoka

Hiroshima

Izumo

Kanazawa

Kawasaki

Kitakyushu

Kobe

Kochi

Koga

Maebashi

Matsumoto

Minato

Nishinomiya

Ohmura

Ohta-Ku

Okayama

Saga

Sapporo

Shimotsuga

Suita

Ube